©2019 by Dicronis GmbH

  • White Twitter Icon
  • White LinkedIn Icon

May 23, 2017

Dicronis announced as a finalist of the MassChallenge Switzerland 2017

Dicronis proud to take part to the MassChallenge accelerator 2017. During the four month summer accelerator, the team will engage in improving the business case.

See the article on Agefi:

http://www.agefi.com/quotidien-agefi/une/detail/edition/2017-05-23/article/exclusif-laccelerateur-de-start-up-a-renens-encourage-les-synergies-sectorielles-avec-65-de-projets-suisses-454247.html

April 28, 2017

Dicronis wins 2nd Stage of Venture Kick

Dicronis was awarded the 2nd Stage of Venture kick to advance the commercial development of its first product in the pipeline, Lymphit. 

April 26, 2017

Dicronis pitch at the Seed Champions Night in Lausanne

Patrizia pitches at the Seed Champions Night together with the 2017 Venture leaders teams. See the video at: http://www.venturekick.ch/index.cfm?CFID=576225487&CFTOKEN=53691298&page=129733&profil_id=13555&BackPage=129731

April 21, 2017

First international recognition - Dicronis features among the MedTech Innovator Top 

 

Dicronis team engaged in the participation of the MedTech Innovator accelerator, an international program with a relevant network of experts and partners.

April 11, 2017

Dicronis to improve his case with the help of CTI coaching 

Dicronis got accepted for coaching by the CTI program, in order to get valid support in the improvement of its business case.

March 16, 2017

Dicronis CEO among the Venture leaders Life Sciences of 2017

Ms. Patrizia Marschalkova is part of the team of the Venture leaders Boston, with focus on Life Sciences. She will travel to the USA (June 2017) and intercontinentally share the vision of Dicrons with like-minded entrepreneurs and investors. Read the interview to Ms. Marschalkova at: http://www.venturelab.ch/index.cfm?CFID=489346262&CFTOKEN=74009989&page=132995&article_id=2694